Lilly's weight loss drug cuts diabetes risk by 94% in three-year trial, company says - NBC News


8/20/2024

Lilly's weight loss drug cuts diabetes risk by 94% in three-year trial, company says  NBC NewsEli Lilly's weight loss drug slashes the risk of developing diabetes in long-term trial  CNBCEli Lilly's weight-loss drug may prevent diabetes — but there's 1 unanswered question  Business InsiderTirzepatide cuts risk of diabetes by 94% in adults with prediabetes and obesity or overweight, drugmaker says  CNNLilly’s Zepbound Cut Risk of Diabetes by 94% in Obese People  Bloomberg...

Original

Tags: company | cut | cuts | drug | loss | nbc | news | risk | trial



Let us know what you think!

Click on a star to rate it!

Average rating 0 / 5. Vote count: 0

No votes so far! Be the first to rate this post.

Leave a Comment

Scroll back to top